ATE411286T1 - Aromatische heterocyclen mit hiv integrase inhibierenden eigenschaften - Google Patents
Aromatische heterocyclen mit hiv integrase inhibierenden eigenschaftenInfo
- Publication number
- ATE411286T1 ATE411286T1 AT99961299T AT99961299T ATE411286T1 AT E411286 T1 ATE411286 T1 AT E411286T1 AT 99961299 T AT99961299 T AT 99961299T AT 99961299 T AT99961299 T AT 99961299T AT E411286 T1 ATE411286 T1 AT E411286T1
- Authority
- AT
- Austria
- Prior art keywords
- aromatic heterocycles
- hiv integrase
- inhibiting properties
- integrase inhibiting
- properties
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP37127098 | 1998-12-25 | ||
| JP24747999 | 1999-09-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE411286T1 true ATE411286T1 (de) | 2008-10-15 |
Family
ID=26538287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99961299T ATE411286T1 (de) | 1998-12-25 | 1999-12-17 | Aromatische heterocyclen mit hiv integrase inhibierenden eigenschaften |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US6620841B1 (de) |
| EP (1) | EP1142872B1 (de) |
| JP (1) | JP3929244B2 (de) |
| KR (1) | KR20010089708A (de) |
| CN (1) | CN1178913C (de) |
| AP (1) | AP2001002169A0 (de) |
| AT (1) | ATE411286T1 (de) |
| AU (1) | AU763040B2 (de) |
| BR (1) | BR9916583A (de) |
| CA (1) | CA2353961A1 (de) |
| CZ (1) | CZ20012160A3 (de) |
| DE (1) | DE69939749D1 (de) |
| HK (1) | HK1042701A1 (de) |
| HU (1) | HUP0201472A3 (de) |
| ID (1) | ID29027A (de) |
| IL (1) | IL143958A0 (de) |
| NO (1) | NO20013179L (de) |
| NZ (1) | NZ512184A (de) |
| PL (1) | PL348596A1 (de) |
| RU (1) | RU2225860C2 (de) |
| TR (1) | TR200101886T2 (de) |
| WO (1) | WO2000039086A1 (de) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6380249B1 (en) | 1998-06-03 | 2002-04-30 | Merck & Co., Inc. | HIV integrase inhibitors |
| US6306891B1 (en) | 1998-06-03 | 2001-10-23 | Merck & Co., Inc. | HIV integrase inhibitors |
| US6262055B1 (en) | 1998-06-03 | 2001-07-17 | Merck & Co., Inc. | HIV integrase inhibitors |
| GB9816358D0 (en) * | 1998-07-27 | 1998-09-23 | Angeletti P Ist Richerche Bio | Enzyme inhibitors |
| US6492423B1 (en) | 1998-07-27 | 2002-12-10 | Istituto Di Ricerche Di Biologia Molecolare Pangeletti Spa | Diketoacid-derivatives as inhibitors of polymerases |
| CA2376043A1 (en) * | 1999-06-02 | 2000-12-14 | Shionogi & Co., Ltd. | Novel processes for the preparation of substituted propenone derivatives |
| JP2003503386A (ja) * | 1999-06-25 | 2003-01-28 | メルク エンド カムパニー インコーポレーテッド | １−（芳香族またはヘテロ芳香族置換）−３−（ヘテロ芳香族置換）−１，３−プロパンジオン類およびそれの使用 |
| MXPA02012160A (es) * | 2000-06-13 | 2003-04-25 | Shionogi & Co | Composiciones medicinales las cuales contienen derivados de propenona. |
| WO2001095905A1 (en) * | 2000-06-14 | 2001-12-20 | Shionogi & Co., Ltd. | Inhibitor for enzyme having two divalent metal ions as active centers |
| AU2002212701A1 (en) * | 2000-11-09 | 2002-05-21 | Shionogi And Co., Ltd. | Drug-tolerant hiv integrases |
| EP2181985B1 (de) * | 2001-08-10 | 2011-10-26 | Shionogi & Co., Ltd. | Antivirales Mittel |
| EP1441735B1 (de) * | 2001-10-26 | 2006-02-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | N-substituierte hydroxypyrimidinoncarboxamid-hemmer der hiv-integrase |
| TW200407132A (en) * | 2001-11-15 | 2004-05-16 | Shionogi & Co | Process for producing 1-H-1,2,4-triazole-3-carboxylic acid ester |
| AU2002349675A1 (en) * | 2001-12-05 | 2003-06-17 | Shionogi And Co., Ltd. | Derivative having hiv integrase inhibitory activity |
| US7358249B2 (en) | 2002-08-13 | 2008-04-15 | Shionogi & Co., Ltd. | Heterocyclic compounds having inhibitory activity against HIV integrase |
| WO2004035577A2 (en) | 2002-10-16 | 2004-04-29 | Gilead Sciences, Inc. | Pre-organized tricyclic integrase inhibitor compounds |
| CN1569803B (zh) * | 2003-07-16 | 2011-04-13 | 中国科学院上海药物研究所 | 芳基β－二酮酸的新制备方法 |
| US20060019952A1 (en) * | 2004-01-29 | 2006-01-26 | Elixir Pharmaceuticals, Inc. | Anti-viral therapeutics |
| CA2578068C (en) * | 2004-08-25 | 2011-08-09 | Ardea Biosciences, Inc. | S-triazolyl .alpha.-mercaptoacetanildes as inhibitors of hiv reverse transcriptase |
| WO2006030807A1 (ja) * | 2004-09-15 | 2006-03-23 | Shionogi & Co., Ltd. | Ｈｉｖインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体 |
| UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
| CN101068533B (zh) * | 2004-12-03 | 2011-04-27 | 默沙东公司 | 含有抗成核剂的药物组合物 |
| US7250421B2 (en) * | 2005-01-31 | 2007-07-31 | University Of Georgia Research Foundation, Inc. | Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase |
| WO2006129134A1 (en) * | 2005-06-01 | 2006-12-07 | Bioalliance Pharma | Synergic combinations comprising a styrylquinoline compound and other hiv infection therapeutic agents |
| AU2007254190A1 (en) | 2006-05-16 | 2007-11-29 | Gilead Sciences, Inc. | Integrase inhibitors |
| US7888375B2 (en) | 2006-07-19 | 2011-02-15 | The University Of Georgia Research Foundation, Inc | Pyridinone diketo acids: inhibitors of HIV replication |
| WO2008041882A1 (fr) * | 2006-10-03 | 2008-04-10 | Viktor Veniaminovich Tets | Procédé pour agir sur les virus au moyen d'une substance à base de 2,8-dithioxo-1h- pyrano[2,3-d;6,5-d'] dipyrimidine et de leurs analogues 10-aza (et variantes) |
| CN102670628B (zh) | 2008-01-25 | 2015-11-25 | 奇默里克斯公司 | 治疗病毒感染的方法 |
| WO2010047774A2 (en) * | 2008-10-20 | 2010-04-29 | The Texas A & M University System | Inhibitors of mycobacterium tuberculosis malate synthase, methods of marking and uses thereof |
| WO2011071849A2 (en) | 2009-12-07 | 2011-06-16 | University Of Georgia Research Foundation, Inc. | Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications |
| EP2534150B1 (de) | 2010-02-12 | 2017-04-05 | Chimerix, Inc. | Verfahren zur behandlung von vireninfektionen |
| CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
| CN101928258B (zh) * | 2010-08-18 | 2014-10-29 | 杭州民生药业有限公司 | 1-(2-取代苯胺基-4-甲基-噻唑-5)-3-取代苯基-丙烯酮衍生物、制备方法及其制药用途 |
| DK2691530T3 (en) | 2011-06-10 | 2018-05-22 | Univ Oregon Health & Science | CMV GLYCOPROTEIN AND RECOMBINANT VECTORS |
| WO2014026033A1 (en) * | 2012-08-08 | 2014-02-13 | University Of Florida Research Foundation, Inc. | Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats |
| LT3067358T (lt) | 2012-12-21 | 2019-11-25 | Gilead Sciences Inc | Policikliniai karbamoilpiridono junginiai ir jų farmacinis panaudojimas |
| NO2865735T3 (de) | 2013-07-12 | 2018-07-21 | ||
| SI3019503T1 (sl) | 2013-07-12 | 2017-11-30 | Gilead Sciences, Inc. | Policiklične karbamoilpiridonske spojine in njihova uporaba za zdravljenje HIV infekcij |
| TW201613936A (en) | 2014-06-20 | 2016-04-16 | Gilead Sciences Inc | Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
| NO2717902T3 (de) | 2014-06-20 | 2018-06-23 | ||
| TWI677489B (zh) | 2014-06-20 | 2019-11-21 | 美商基利科學股份有限公司 | 多環型胺甲醯基吡啶酮化合物之合成 |
| TWI695003B (zh) | 2014-12-23 | 2020-06-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
| SI3466490T1 (sl) | 2015-04-02 | 2020-12-31 | Gilead Sciences, Inc. | Policiklične spojine karbamoilpiridona in njihova farmacevtska uporaba |
| CN106905244B (zh) * | 2017-02-27 | 2019-08-16 | 武汉工程大学 | 二芳基嘧啶-二酮酸类杂合型hiv-1抑制剂及其制备方法 |
| CN114829357A (zh) * | 2019-10-28 | 2022-07-29 | 中国科学院上海药物研究所 | 五元杂环氧代羧酸类化合物及其医药用途 |
| CN111943899B (zh) * | 2020-09-08 | 2023-04-21 | 河北凯诺中星科技有限公司 | 一种5-甲酸乙酯四氮唑的合成方法 |
| CN113683574B (zh) * | 2021-09-06 | 2023-11-17 | 上海晋鲁医药科技有限公司 | 一种合成1-甲基-1h-1,2,4-三唑-3-甲酸甲酯的方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3899508A (en) | 1974-04-12 | 1975-08-12 | Lilly Co Eli | 5-(2-Aminophenyl)pyrazole-3-carboxylic acids and esters thereof |
| US3931247A (en) | 1974-12-11 | 1976-01-06 | Morton-Norwich Products, Inc. | 5-(Substituted)phenylfurfuryl alcohols |
| JPS5811878B2 (ja) | 1974-12-19 | 1983-03-04 | 大正製薬株式会社 | フロ （ ３ ２−ｂ ） インド−ルルイノ セイホウ |
| JPS56100784A (en) | 1980-01-16 | 1981-08-12 | Yoshitomi Pharmaceut Ind Ltd | Indolizine derivative |
| US4273776A (en) | 1980-01-30 | 1981-06-16 | E. R. Squibb & Sons, Inc. | Antibacterial and antifungal derivatives of 3-(1H-imidazol-1-yl)-2-propen-1-ones |
| US4336397A (en) | 1980-12-29 | 1982-06-22 | Merck & Co., Inc. | 2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4423063A (en) | 1980-12-29 | 1983-12-27 | Merck & Co., Inc. | 2,4-Dioxo-4-substituted-1-butaoic acid derivatives useful in treating urinary track calcium oxalate lithiasis |
| US4332735A (en) | 1981-07-06 | 1982-06-01 | Morton-Norwich Products, Inc. | Antifungal compound |
| US4637829A (en) | 1984-04-27 | 1987-01-20 | Ciba-Geigy Corporation | Sulfonylureas |
| JPS61134346A (ja) | 1984-12-03 | 1986-06-21 | Shionogi & Co Ltd | ４−オキソカルボン酸誘導体および抗潰瘍剤 |
| CA1334975C (en) | 1987-11-13 | 1995-03-28 | James H. Holms | Furan and pyrrole containing lipoxygenase inhibiting compounds |
| JPH0238403A (ja) | 1988-07-28 | 1990-02-07 | Canon Inc | 光重合性組成物および記録媒体 |
| PH27357A (en) | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| US5192773A (en) * | 1990-07-02 | 1993-03-09 | Vertex Pharmaceuticals, Inc. | Immunosuppressive compounds |
| TW224974B (de) * | 1991-07-02 | 1994-06-11 | Hoffmann La Roche | |
| EP0658559A1 (de) * | 1993-12-14 | 1995-06-21 | Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. | Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren |
| US5475109A (en) | 1994-10-17 | 1995-12-12 | Merck & Co., Inc. | Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease |
| US5693804A (en) * | 1994-11-17 | 1997-12-02 | Molecular Geriatrics Corporation | Substituted 1-aryl-3-piperazin-1'-yl propanones |
| CN1254335A (zh) | 1997-04-04 | 2000-05-24 | 辉瑞产品公司 | 烟酰胺衍生物 |
| IL122591A0 (en) | 1997-12-14 | 1998-06-15 | Arad Dorit | Pharmaceutical compositions comprising cystein protease inhibitors |
| EP1069111A4 (de) | 1998-03-26 | 2001-06-06 | Shionogi & Co | Indol derivate mit antiviraler aktivität |
| WO1999048371A1 (en) | 1998-03-27 | 1999-09-30 | The Regents Of The University Of California | Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors |
| WO1999062513A1 (en) | 1998-06-03 | 1999-12-09 | Merck & Co., Inc. | Hiv integrase inhibitors |
| CA2333707A1 (en) | 1998-06-03 | 1999-12-09 | Melissa Egbertson | Hiv integrase inhibitors |
| WO1999062897A1 (en) | 1998-06-03 | 1999-12-09 | Merck & Co., Inc. | Hiv integrase inhibitors |
| JP2003503386A (ja) | 1999-06-25 | 2003-01-28 | メルク エンド カムパニー インコーポレーテッド | １−（芳香族またはヘテロ芳香族置換）−３−（ヘテロ芳香族置換）−１，３−プロパンジオン類およびそれの使用 |
-
1999
- 1999-12-17 DE DE69939749T patent/DE69939749D1/de not_active Expired - Lifetime
- 1999-12-17 CZ CZ20012160A patent/CZ20012160A3/cs unknown
- 1999-12-17 HU HU0201472A patent/HUP0201472A3/hu unknown
- 1999-12-17 US US09/857,632 patent/US6620841B1/en not_active Expired - Fee Related
- 1999-12-17 ID IDW00200101355A patent/ID29027A/id unknown
- 1999-12-17 BR BR9916583-0A patent/BR9916583A/pt not_active IP Right Cessation
- 1999-12-17 KR KR1020017008150A patent/KR20010089708A/ko not_active Application Discontinuation
- 1999-12-17 WO PCT/JP1999/007101 patent/WO2000039086A1/ja not_active Application Discontinuation
- 1999-12-17 IL IL14395899A patent/IL143958A0/xx unknown
- 1999-12-17 AT AT99961299T patent/ATE411286T1/de not_active IP Right Cessation
- 1999-12-17 AP APAP/P/2001/002169A patent/AP2001002169A0/en unknown
- 1999-12-17 PL PL99348596A patent/PL348596A1/xx not_active Application Discontinuation
- 1999-12-17 JP JP2000590998A patent/JP3929244B2/ja not_active Expired - Fee Related
- 1999-12-17 TR TR2001/01886T patent/TR200101886T2/xx unknown
- 1999-12-17 CN CNB99816285XA patent/CN1178913C/zh not_active Expired - Fee Related
- 1999-12-17 RU RU2001120016/04A patent/RU2225860C2/ru not_active IP Right Cessation
- 1999-12-17 NZ NZ512184A patent/NZ512184A/xx unknown
- 1999-12-17 AU AU17979/00A patent/AU763040B2/en not_active Ceased
- 1999-12-17 CA CA002353961A patent/CA2353961A1/en not_active Abandoned
- 1999-12-17 EP EP99961299A patent/EP1142872B1/de not_active Expired - Lifetime
-
2001
- 2001-06-22 NO NO20013179A patent/NO20013179L/no not_active Application Discontinuation
-
2002
- 2002-06-04 HK HK02104241.7A patent/HK1042701A1/zh unknown
- 2002-11-06 US US10/288,380 patent/US6645956B1/en not_active Expired - Fee Related
-
2003
- 2003-06-18 US US10/463,816 patent/US7098201B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| RU2225860C2 (ru) | 2004-03-20 |
| NO20013179L (no) | 2001-08-27 |
| JP3929244B2 (ja) | 2007-06-13 |
| HK1042701A1 (zh) | 2002-08-23 |
| EP1142872B1 (de) | 2008-10-15 |
| WO2000039086A1 (fr) | 2000-07-06 |
| HUP0201472A2 (hu) | 2003-10-28 |
| US6620841B1 (en) | 2003-09-16 |
| AP2001002169A0 (en) | 2001-06-30 |
| PL348596A1 (en) | 2002-06-03 |
| ID29027A (id) | 2001-07-26 |
| DE69939749D1 (de) | 2008-11-27 |
| NZ512184A (en) | 2003-08-29 |
| US7098201B2 (en) | 2006-08-29 |
| KR20010089708A (ko) | 2001-10-08 |
| BR9916583A (pt) | 2001-09-25 |
| TR200101886T2 (tr) | 2001-12-21 |
| IL143958A0 (en) | 2002-04-21 |
| RU2001120016A (ru) | 2003-12-10 |
| EP1142872A4 (de) | 2002-04-17 |
| CN1178913C (zh) | 2004-12-08 |
| AU1797900A (en) | 2000-07-31 |
| NO20013179D0 (no) | 2001-06-22 |
| AU763040B2 (en) | 2003-07-10 |
| EP1142872A1 (de) | 2001-10-10 |
| US6645956B1 (en) | 2003-11-11 |
| HUP0201472A3 (en) | 2006-03-28 |
| CZ20012160A3 (cs) | 2001-10-17 |
| CA2353961A1 (en) | 2000-07-06 |
| US20040002485A1 (en) | 2004-01-01 |
| CN1335834A (zh) | 2002-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE411286T1 (de) | Aromatische heterocyclen mit hiv integrase inhibierenden eigenschaften | |
| DE59706518D1 (de) | Polymere mit antimikrobiellen eigenschaften | |
| DE60022199D1 (de) | Tamponapplikator mit verbesserter greifmöglichkeit | |
| DE60044437D1 (de) | Aufzug mit zugangssicherheit | |
| ATE308319T1 (de) | Dosierungsform mit verlängerter wirkstoffabgabe | |
| DE69904162D1 (de) | Chinolinderivate | |
| DK1095021T3 (da) | Quinolinderivater | |
| EE200200175A (et) | Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine | |
| DE60039626D1 (de) | Vorrichtungen zur verabreichung von arzneistoffen mit antiprogestinischen eigenschaften | |
| DE69904333D1 (de) | Chinolinderivate | |
| DE60013020D1 (de) | Spritze mit Verriegelungsmechanismus | |
| DE60034628D1 (de) | Hebezeug | |
| DE60007928D1 (de) | Kran | |
| MA26613A1 (fr) | Pyrroles substitues | |
| NO20004717L (no) | Sikkerhetskile-lukkehode | |
| DE60013714D1 (de) | Kran | |
| DE69920387D1 (de) | Stapeleinheit | |
| DE60008363D1 (de) | Flammhemmende mischung welche monomere und oligomere flammhemmer enthält | |
| ATE281436T1 (de) | Chinolin-4-yl-derivate | |
| DE69940831D1 (de) | Hochschlagfeste aromatische monovinylidenpolymere | |
| MA26860A1 (fr) | Pyrroles substitues. | |
| ATA38499A (de) | Aufspulvorrichtung | |
| ID25518A (id) | Tenunan pita ritsleting | |
| KR980002827U (ko) | 크레인 | |
| DE69933597D1 (de) | Hebezeug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |